A Review of the Role of CpG Oligodeoxynucleotides as Toll-Like Receptor 9 Agonists in Prophylactic and Therapeutic Vaccine Development in Infectious Diseases

Author： Gupta Kaveri  

Publisher： Adis International

ISSN： 1174-5886

Source： Drugs in R&D, Vol.9, Iss.3, 2008-01, pp. : 137-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Toll-like receptor 9 agonists as cancer therapeutics

By Holtick Udo   Scheulen Max E   von Bergwelt-Baildon Michael S   Weihrauch Martin R  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 3, 2011-03 ,pp. : 361-372

Informa Healthcare

Access to resources Recommend Favorite

Activation and Regulation of Toll-like Receptor 9: CpGs and Beyond

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 6, 2008-06 ,pp. : 590-600

Bentham Science Publishers

Access to resources Recommend Favorite

Toll-like receptor agonists: a patent review (2011 – 2013)

By Hussein Waleed M   Liu Tzu-Yu   Skwarczynski Mariusz   Toth Istvan  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 4, 2014-04 ,pp. : 453-470

Informa Healthcare

Access to resources Recommend Favorite

Modifying Toll-like Receptor 9 Signaling for Therapeutic Use

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 3, 2006-03 ,pp. : 287-291

Bentham Science Publishers

Access to resources Recommend Favorite

Toll-Like Receptors in Human Infectious Diseases

By  

Current Pharmaceutical Design, Vol. 12, Iss. 32, 2006-11 ,pp. : 4173-4184

Bentham Science Publishers

Access to resources Recommend Favorite